Drug comparisons
Linagliptin vs Sotagliflozin
Linagliptin vs Sotagliflozin: DPP-4 vs dual SGLT1/SGLT2 for T2D & HF. Compare CV benefits, efficacy, side effects & which is better.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting between a DPP-4 inhibitor and dual SGLT inhibitor for type 2 diabetes, especially with heart failure or CV risk.
Bottom line
Sotagliflozin often provides superior heart failure and CV benefits over Linagliptin, but the latter may be preferred to avoid SGLT-related risks.
All medication comparisons